Mike Raymer joins Jeremy for Episode 30 of the OverReaction Podcast. Healthcare tech OG with stints at IDX, @GEHealthCare, Misys, @Microsoft & M*Modal. Led innovative startups like Pro-ficiency & Vitalchat. Now also an active Angel Investor.
https://t.co/MHXJ4NX3EB
Follower counts are up. Engagement is down. Boosted Posts are everywhere. So we asked industry peers: Is LinkedIn becoming "too" pay-to-play? Here’s what we found…
https://t.co/4VIhUzMccc
Robert talks about the shift he’s experienced recently going from years of abject skepticism to FDA approval to sudden significant market excitement about @UltrasoundAI. This is very common for successful start-ups.
https://t.co/Op6nsr50QI
Robert Bunn joins Jeremy for episode 29 of the OverReaction podcast. Bob is one of the most fascinating people in healthcare. He’s developed cutting edge AI technology to dramatically improve maternal-fetal health.
@UltrasoundAI@ReactionData
https://t.co/UModiGw7Cd
In this clip, Darrell contrasts how startups eagerly embrace new and unconventional ideas, while big companies resist due to deeply entrenched conformity and risk-aversion.
https://t.co/LdEIIxmhWh
Darrell and Jeremy discuss how most organizations strongly resist real strategic thinking due to a pervasive culture of conformity.
https://t.co/0xMdSQ8Inr
In this clip, Dan dives into AI in healthcare, particularly the fact that the investor community cares a lot more about AI than customers do.
https://t.co/z5gmiwji44
More leads ≠ More revenue. In our latest article, we dive into how the most successful B2B strategies are pivoting from "how many" to "how qualified."
https://t.co/nh5HyCSzQa
Kevin and Jeremy discuss California's problematic unrealized gains tax proposal and why politicians like Ro Khanna so often deeply misunderstand the nuances of finance.
https://t.co/r6gkr23WXB
If your CX program feels stuck on dashboards and surveys without real change… this one's for you. Moving beyond tools to guided, outcome-focused customer relationships.
https://t.co/3hu7ros3Gs
With ViVE kicking off in late February and HIMSS in March, the calendar is packed for healthcare innovators in Q1. Reaction Data's recent poll captures real sentiment on attendance intentions. See the results here:
https://t.co/RS4Efwi7jh
Kevin Barnes is this week’s guest on the podcast. Kevin is a healthcare M&A maestro and an expert in corporate development.
https://t.co/kiHCGzTMLz
Mary discusses RockITdata’s innovative culture, trust-based values, and focus on delivering faster, more cost-effective solutions for government clients.
https://t.co/oUHh28E5F2
In this segment, Mary discusses integrating commercial tech expertise into the government ecosystem, particularly the role of Silicon Valley outsiders.
https://t.co/hQvioBhYHs
In this clip, Mary discusses federal health IT progress, primarily HHS's shift from siloed to shared data ecosystems and important FDA acquisition reforms under Dr. Barclay Butler.
https://t.co/6BrPBG9d8Q
The most accurate ideal customer profile is built by analyzing your happiest existing customers, not by guessing which prospects might convert. Read our latest article to find out more...
https://t.co/i9X51cWtJN
Mary Womack joins Jeremy for episode 25 of the OverReaction podcast. Mary is a Federal Health IT strategist and the author of "Mission Meets Tech," a LinkedIn newsletter exploring the intersection of defense, digital health, and innovation.
https://t.co/gjSLmyCDmi